{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:24:23Z","timestamp":1750098263966},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T00:00:00Z","timestamp":1324512000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00277-011-1387-9","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T02:10:44Z","timestamp":1324433444000},"page":"723-728","source":"Crossref","is-referenced-by-count":16,"title":["Plasmacytic differentiation in MALT lymphomas following treatment with rituximab"],"prefix":"10.1007","volume":"91","author":[{"given":"Marlene","family":"Troch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Kiesewetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Dolak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"P\u00fcsp\u00f6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonhard","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Chott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Raderer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,22]]},"reference":[{"issue":"6","key":"1387_CR1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1023\/A:1008396618983","volume":"10","author":"PG Isaacson","year":"1999","unstructured":"Isaacson PG (1999) Gastric MALT-lymphoma: from concept to cure. Ann Oncol 10(6):637\u2013645","journal-title":"Ann Oncol"},{"key":"1387_CR2","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","volume":"52","author":"P Isaacson","year":"1983","unstructured":"Isaacson P, Wright DH (1983) Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 52:1410\u20131416","journal-title":"Cancer"},{"issue":"12","key":"1387_CR3","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/annonc\/mdm375","volume":"18","author":"S W\u00f6hrer","year":"2007","unstructured":"W\u00f6hrer S, Troch M, Streubel B et al (2007) Pathology and clinical course of MALT lymphoma with plasmacytic differentiation. Ann Oncol 18(12):2020\u20132024","journal-title":"Ann Oncol"},{"issue":"12","key":"1387_CR4","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00000478-200012000-00001","volume":"24","author":"JP Huyen Van","year":"2000","unstructured":"Van Huyen JP, Molina T, Delmer A et al (2000) Splenic marginal zone lymphoma with or without plasmacytic differentiation. Am J Surg Pathol 24(12):1581\u20131592","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"1387_CR5","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/annonc\/mdl295","volume":"17","author":"M Hoffmann","year":"2006","unstructured":"Hoffmann M, W\u00f6hrer S, Becherer A, Chott A, Streubel B, Kletter K, Raderer M (2006) 18\u00a0F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference. Ann Oncol 17(12):1761\u20131765","journal-title":"Ann Oncol"},{"key":"1387_CR6","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/annonc\/mdn760","volume":"20","author":"A Stathis","year":"2009","unstructured":"Stathis A, Chini C, Bertoni F et al (2009) Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol 20:1086\u20131093","journal-title":"Ann Oncol"},{"issue":"3","key":"1387_CR7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2141.2008.07486.x","volume":"144","author":"BW Hancock","year":"2009","unstructured":"Hancock BW, Qian W, Linch D, Delchier JC, Smith P, Jakupovic I, Burton C, Souhami R, Wotherspoon A, Copie-Bergman C, Capella C, Traulle C, Levy M, Cortelazzo S, Ferreri AJ, Ambrosetti A, Pinotti G, Martinelli G, Vitolo U, Cavalli F, Gisselbrecht C, Zucca E (2009) Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. Br J Haematol 144(3):367\u2013375","journal-title":"Br J Haematol"},{"issue":"5","key":"1387_CR8","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3324\/haematol.2008.001537","volume":"94","author":"M Troch","year":"2009","unstructured":"Troch M, Jonak C, M\u00fcllauer L, P\u00fcsp\u00f6k A, Formanek M, Hauff W, Zielinski CC, Chott A, Raderer M (2009) A phase II study of bortezomib in patients with MALT lymphoma. Haematologica 94(5):738\u2013742","journal-title":"Haematologica"},{"issue":"22","key":"1387_CR9","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1002\/cncr.24605","volume":"115","author":"A Salar","year":"2009","unstructured":"Salar A, Domingo-Domenech E, Estany C, Canales MA, Gallardo F, Servitje O, Fraile G, Montalb\u00e1n C (2009) Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Cancer 115(22):5210\u20135217","journal-title":"Cancer"},{"key":"1387_CR10","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","volume":"23","author":"G Martinelli","year":"2005","unstructured":"Martinelli G, Laszlo D, Ferreri AJ et al (2005) Clinical activity of rituximab in gastric marginal zone non-Hodgkin\u2019s lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 23:1979\u20131983","journal-title":"J Clin Oncol"},{"issue":"4","key":"1387_CR11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000074641","volume":"65","author":"M Raderer","year":"2003","unstructured":"Raderer M, J\u00e4ger G, Brugger S, P\u00fcsp\u00f6k A, Fiebiger W, Drach J, Wotherspoon A, Chott A (2003) Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology 65(4):306\u2013310","journal-title":"Oncology"},{"key":"1387_CR12","volume-title":"WHO classification of tumors of haematopoietic and lymphod tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumors of haematopoietic and lymphod tissues, 4th edn. IARC, Lyon","edition":"4"},{"issue":"19","key":"1387_CR13","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1200\/JCO.2006.06.0723","volume":"24","author":"M Raderer","year":"2006","unstructured":"Raderer M, W\u00f6hrer S, Streubel B, Troch M, Turetschek K, J\u00e4ger U, Skrabs C, Gaiger A, Drach J, Puespoek A, Formanek M, Hoffmann M, Hauff W, Chott A (2006) Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 24(19):3136\u20133141","journal-title":"J Clin Oncol"},{"key":"1387_CR14","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","volume":"52","author":"C Copie-Bergman","year":"2003","unstructured":"Copie-Bergman C, Gaulard P, Lavergne-Slove A et al (2003) Proposal for a new histological grading system for posttreatment evaluation of gastric MALT lymphoma. Gut 52:1656","journal-title":"Gut"},{"issue":"2","key":"1387_CR15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V96.2.410","volume":"96","author":"E Zucca","year":"2000","unstructured":"Zucca E, Bertoni F, Roggero E, Cavalli F (2000) The gastric marginal B-cell lymphoma of MALT type. Blood 96(2):410\u2013419","journal-title":"Blood"},{"issue":"31","key":"1387_CR16","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","volume":"23","author":"T W\u00fcndisch","year":"2005","unstructured":"W\u00fcndisch T, Thiede C, Morgner A et al (2005) Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 23(31):8018\u20138024","journal-title":"J Clin Oncol"},{"key":"1387_CR17","unstructured":"Ruskone-Fourmestraux A, Fischbach W, Aleman BM, Boot H, Du MQ, Megraud F, Montalban C, Raderer M, Savio A, Wotherspoon A; on behalf of the EGILS group (2011). EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 60(6):747\u2013758"},{"issue":"1","key":"1387_CR18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/MO:22:1:057","volume":"22","author":"A Aviles","year":"2005","unstructured":"Aviles A, Nambo MJ, Neri N, Talavera A, Cleto S (2005) Mucosa associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled trial. Med Oncol 22(1):57\u201362","journal-title":"Med Oncol"},{"issue":"11","key":"1387_CR19","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1080\/10428190500178399","volume":"46","author":"S Woehrer","year":"2005","unstructured":"Woehrer S, Streubel B, Chott A et al (2005) Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab. Leuk Lymphoma 46(11):1645\u20131649","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"1387_CR20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/10428194.2010.534519","volume":"52","author":"M Hoffmann","year":"2011","unstructured":"Hoffmann M, Troch M, Eidherr H, Traub-Weidinger T, Jonak C, Muellauer L, Raderer M (2011) 90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma. Leuk Lymphoma 52(1):42\u201345","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"1387_CR21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/annonc\/mdn692","volume":"20","author":"B Esmaeli","year":"2009","unstructured":"Esmaeli B, McLaughlin P, Pro B, Samaniego F, Gayed I, Hagemeister F, Romaguera J, Cabanillas F, Neelapu SS, Banay R, Fayad L, Wayne Saville M, Kwak LW (2009) Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma. Ann Oncol 20(4):709\u2013714","journal-title":"Ann Oncol"},{"issue":"2","key":"1387_CR22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.leukres.2009.04.003","volume":"34","author":"E Orciuolo","year":"2009","unstructured":"Orciuolo E, Buda G, Sordi E et al (2009) 2CdA chemotherapy and rituximab in the treatment of marginal zone lymphoma. Leuk Res 34(2):184\u2013189","journal-title":"Leuk Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1387-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-011-1387-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1387-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T01:58:26Z","timestamp":1593395906000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-011-1387-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,22]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1387"],"URL":"https:\/\/doi.org\/10.1007\/s00277-011-1387-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,22]]}}}